Active — Not RecruitingNot Applicable

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

United States400 participantsStarted 2021-01-12

Plain-language summary

The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Participation in other observational studies is not exclusionary
✕. It is anticipated that some participants enrolled in EXPLORE-MG2 may be enrolled in future interventional trials while active in EXPLORE-MG2. This is acceptable. The exclusion only applies to starting EXPLORE-MG2 when participation in an interventional trial is imminent or active.
✕. If an EXPLORE-MG2 participant is later enrolled in an interventional trial, it will be at the investigator's discretion whether to continue collecting biosamples while the patient is participating in the interventional trial. Collection of natural history data should continue.

What they're measuring

The number of participants enrolled and serial blood reported at the conclusion of the enrollment period.

Timeframe: 5 years

Trial details

NCT IDNCT06002945

SponsorYale University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Myasthenia Gravis trials